Hospira (HSP) announced late yesterday that Michael Ball would become the company's new CEO and...


Hospira (HSP) announced late yesterday that Michael Ball would become the company's new CEO and a member of the board, effective March 28. Ball, currently the president of Allergan (AGN), will succeed Christopher Begley, Hospira's founding CEO. Begley will assume the role of executive chairman.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs